Prediction of UGT-mediated phase II metabolism via ligand- and structure-based predictive models

The prediction of drugs metabolism by in silico techniques is gaining a growing interest due to the possibility to process large datasets allowing the stability and safety of new drug candidates to be evaluated during the early stages of the drug discovery process. To date, in silico models for metabolism prediction mainly exploits the ligand-based (LB) properties of the training molecules to predict the occurrence of a given metabolic reaction and/or the reactive site involved in the biotransformation. However, recent reports highlighted that structure-based (SB) modeling can be conveniently integrated with LB methods for drug metabolism prediction purpose, with the advantages to predict if a given molecule can fit the enzyme active site and which moiety approaches the catalytic residues. Herein, we developed machine learning models for UDP-glucuronosyltransferase (UGT)-mediated metabolism by using both LB and SB methods. In particular, this study was focused on UGT2B7 and UGT2B15 isoforms which are involved in the clearance of many drugs as well as in clinically relevant drug-drug interactions. First, molecular dynamics (MD) and docking simulations were combined to explore the binding mechanism of cofactor and substrate within the catalytic pocket of the studied UGT isoforms exploiting their AlphaFold structures. The analysis of the MD trajectories allowed an appropriate conformation of both UGT isoforms to be identified for the development of binary classification models. For this purpose, Random Forest algorithm and the metabolic data extracted from the MetaQSAR database were used. SB models were trained on a set of scoring functions and protein-ligand interaction fingerprints derived from docking, while the LB models were built on a set of physicochemical and constitutional descriptors. When the single models were evaluated, the LB classifiers outperformed the SB models. However, the application of a consensus strategy led to an improvement of the prediction accuracy if compared to the individual models, highlighting that LB and SB approaches convey complementary information whose aggregation allowed us to achieve better predictions than the single models.

Authors

Institutions

Publication Details

Journal
Journal of Cheminformatics
Published
2025-10-15
DOI
https://doi.org/10.1186/s13321-025-01097-y
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prediction of UGT-mediated phase II metabolism via ligand- and structure-based predictive models

Alessandro Pedretti, Angelica Mazzolari, Serena Vittorio, Giulio Vistoli et al.
Journal of Cheminformatics
Computational Drug Discovery Methods
article

Prediction of UGT-mediated phase II metabolism via ligand- and structure-based predictive models

Alessandro Pedretti, Angelica Mazzolari, Serena Vittorio, Giulio Vistoli, Andrea R. Beccari, Filippo Lunghini, Akash Deep Biswas, Emanuela Sabato, Luna Del Bono
article en

Abstract

The prediction of drugs metabolism by in silico techniques is gaining a growing interest due to the possibility to process large datasets allowing the stability and safety of new drug candidates to be evaluated during the early stages of the drug discovery process. To date, in silico models for metabolism prediction mainly exploits the ligand-based (LB) properties of the training molecules to predict the occurrence of a given metabolic reaction and/or the reactive site involved in the biotransformation. However, recent reports highlighted that structure-based (SB) modeling can be conveniently integrated with LB methods for drug metabolism prediction purpose, with the advantages to predict if a given molecule can fit the enzyme active site and which moiety approaches the catalytic residues. Herein, we developed machine learning models for UDP-glucuronosyltransferase (UGT)-mediated metabolism by using both LB and SB methods. In particular, this study was focused on UGT2B7 and UGT2B15 isoforms which are involved in the clearance of many drugs as well as in clinically relevant drug-drug interactions. First, molecular dynamics (MD) and docking simulations were combined to explore the binding mechanism of cofactor and substrate within the catalytic pocket of the studied UGT isoforms exploiting their AlphaFold structures. The analysis of the MD trajectories allowed an appropriate conformation of both UGT isoforms to be identified for the development of binary classification models. For this purpose, Random Forest algorithm and the metabolic data extracted from the MetaQSAR database were used. SB models were trained on a set of scoring functions and protein-ligand interaction fingerprints derived from docking, while the LB models were built on a set of physicochemical and constitutional descriptors. When the single models were evaluated, the LB classifiers outperformed the SB models. However, the application of a consensus strategy led to an improvement of the prediction accuracy if compared to the individual models, highlighting that LB and SB approaches convey complementary information whose aggregation allowed us to achieve better predictions than the single models.

Journal of CheminformaticsVol. 17(1)
University of Milan (IT), Dompé (Italy) (IT), Farmaceutici Damor (Italy) (IT)
Openalex Percentile: Top 69%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.